ASCO Annual Meeting 2022: An Innovation Showcase in Cancer Treatment
Editor’s Note: Please hover over the terms highlighted in sea green for their definitions. The glossary at the end also includes these in ... By Arelis Agosto
Thoroughly researched perspectives and commentary on the trends shaping global markets. Subscribe to Updates →
Arelis (Lis) started with Global X in 2022 as a Research Analyst covering healthcare-related funds in the Thematic Growth suite of ETFs. Prior to joining Global X, she worked as a Senior Healthcare Analyst at Third Bridge, covering US life sciences, diagnostics, biotech, pharmaceutical services, and animal health. Lis holds a BA from Babson College in Business, with a concentration in Global Businesses Management. She is a native speaker of both English and Spanish.
Editor’s Note: Please hover over the terms highlighted in sea green for their definitions. The glossary at the end also includes these in ... By Arelis Agosto
Editor’s Note: Hover over terms in sea green for a pop-out glossary definition. Full glossary also included at the end with terms listed in ... By Arelis Agosto
Patience can be a virtue in the genomic space, as next-generation biotech treatments don’t hit the market overnight. However, when all the ... By Arelis Agosto
A look at ongoing legislative policy and its expected impact on the Telemedicine & Digital Health space. By Arelis Agosto
Investing involves risk, including the possible loss of principal. Diversification does not ensure a profit or guarantee against a loss. This information is not intended to be individual or personalized investment or tax advice and should not be used for trading purposes. Please consult a financial advisor or tax professional for more information regarding your investment and/or tax situation.
Information provided by Global X Management Company LLC.